These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22104352)

  • 21. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
    Medich DC; Munro JJ
    Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosimetric study of a new polymer encapsulated palladium-103 seed.
    Bernard S; Vynckier S
    Phys Med Biol; 2005 Apr; 50(7):1493-504. PubMed ID: 15798339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photon spectrometry for the determination of the dose-rate constant of low-energy photon-emitting brachytherapy sources.
    Chen ZJ; Nath R
    Med Phys; 2007 Apr; 34(4):1412-30. PubMed ID: 17500473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental and Monte Carlo determination of the TG-43 dosimetric parameters for the model 9011 THINSeed brachytherapy source.
    Kennedy RM; Davis SD; Micka JA; DeWerd LA
    Med Phys; 2010 Apr; 37(4):1681-8. PubMed ID: 20443489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monte Carlo calculations and experimental measurements of dosimetric parameters of the IRA-103Pd brachytherapy source.
    Sadeghi M; Raisali G; Hosseini SH; Shavar A
    Med Phys; 2008 Apr; 35(4):1288-94. PubMed ID: 18491522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental determination of the TG-43 dosimetric characteristics of EchoSeed model 6733 I25I brachytherapy source.
    Meigooni AS; Dini SA; Sowards K; Hayes JL; Al-Otoom A
    Med Phys; 2002 Jun; 29(6):939-42. PubMed ID: 12094988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dosimetry of the 198Au source used in interstitial brachytherapy.
    Dauffy LS; Braby LA; Berner BM
    Med Phys; 2005 Jun; 32(6):1579-88. PubMed ID: 16013717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monte Carlo dosimetric study of best industries and Alpha Omega Ir-192 brachytherapy seeds.
    Ballester F; Granero D; Pérez-Calatayud J; Casal E; Puchades V
    Med Phys; 2004 Dec; 31(12):3298-305. PubMed ID: 15651612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosimetry parameters of BARC OcuProsta I-125 seed source.
    Sharma SD; Basu M; Shanta A; Selvam TP; Tripathi UB; Bhatt BC
    Australas Phys Eng Sci Med; 2005 Mar; 28(1):14-20. PubMed ID: 15920985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric characteristic of a new 125I brachytherapy source.
    Sadeghi M; Khanmohammadi Z
    Radiat Prot Dosimetry; 2011 Nov; 147(3):451-6. PubMed ID: 21233096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
    Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
    Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetric characteristics of the DRAXIMAGE model LS-1 1-125 interstitial brachytherapy source design: a Monte Carlo investigation.
    Williamson JF
    Med Phys; 2002 Apr; 29(4):509-21. PubMed ID: 11991122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monte Carlo and experimental characterization of the first AMIRS 103Pd brachytherapy source.
    Raisali G; Ghonchehnazi MG; Shokrani P; Sadeghi M
    Appl Radiat Isot; 2008 Dec; 66(12):1856-60. PubMed ID: 18657981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosimetric characterization of a newly designed encapsulated interstitial brachytherapy source of iodine-125-model LS-1 BrachySeed.
    Nath R; Yue N
    Appl Radiat Isot; 2001 Dec; 55(6):813-21. PubMed ID: 11761105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of the dosimetric characteristics of InterSource125 iodine brachytherapy source.
    Meigooni AS; Yoe-Sein MM; Al-Otoom AY; Sowards KT
    Appl Radiat Isot; 2002 Apr; 56(4):589-99. PubMed ID: 11999157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric characterization of an encapsulated interstitial brachytherapy source of 125I on a tungsten substrate.
    Nath R; Yue N
    Brachytherapy; 2002; 1(2):102-9. PubMed ID: 15062178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monte Carlo calculation of dosimetry parameters for the IR08-103Pd brachytherapy source.
    Saidi P; Sadeghi M; Shirazi A; Tenreiro C
    Med Phys; 2010 Jun; 37(6):2509-15. PubMed ID: 20632562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental measurements and Monte Carlo calculations of dosimetric parameters of the IRA1-103Pd brachytherapy source.
    Sadeghi M; Hosseini SH; Raisali G
    Appl Radiat Isot; 2008 Oct; 66(10):1431-7. PubMed ID: 18387806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental determination of dosimetric characterization of a newly designed encapsulated interstitial brachytherapy source of 103Pd-model Pd-1.
    Nath R; Yue N; Roa E
    Med Phys; 2002 Oct; 29(10):2433-4. PubMed ID: 12408318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Model 3500 125I brachytherapy source dosimetric characterization.
    Wallace RE
    Appl Radiat Isot; 2002 Apr; 56(4):581-7. PubMed ID: 11999156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.